These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 25526566)

  • 1. Lidocaine sensitizes the cytotoxicity of cisplatin in breast cancer cells via up-regulation of RARβ2 and RASSF1A demethylation.
    Li K; Yang J; Han X
    Int J Mol Sci; 2014 Dec; 15(12):23519-36. PubMed ID: 25526566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amide-type local anesthetics may suppress tumor cell proliferation and sensitize Human Hepatocellular Carcinoma Cells to Cisplatin
    Chen D; Yan Y; Xie J; Pan J; Chen Y; Li Q; Yuan Y; Zeng W; Xing W
    J Cancer; 2020; 11(24):7312-7319. PubMed ID: 33193895
    [No Abstract]   [Full Text] [Related]  

  • 3. Lidocaine time- and dose-dependently demethylates deoxyribonucleic acid in breast cancer cell lines in vitro.
    Lirk P; Berger R; Hollmann MW; Fiegl H
    Br J Anaesth; 2012 Aug; 109(2):200-7. PubMed ID: 22542536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylation of Ras association domain family protein 1, isoform A correlated with proliferation and drug resistance in hepatocellular carcinoma cell line SMMC-7721.
    Zhao QZ; Dou KF
    J Gastroenterol Hepatol; 2007 May; 22(5):683-9. PubMed ID: 17444856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of retinoic acid on the growth of isogenic metastatic and non-metastatic breast cancer cell lines and their association with distinct expression of retinoic acid receptor beta isoforms 2 and 4.
    Hayashi K; Goodison S; Urquidi V; Tarin D; Lotan R; Tahara E
    Int J Oncol; 2003 Mar; 22(3):623-9. PubMed ID: 12579317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence of epigenetic changes affecting the chromatin state of the retinoic acid receptor beta2 promoter in breast cancer cells.
    Sirchia SM; Ferguson AT; Sironi E; Subramanyan S; Orlandi R; Sukumar S; Sacchi N
    Oncogene; 2000 Mar; 19(12):1556-63. PubMed ID: 10734315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactivation of the tumour suppressor RASSF1A in breast cancer by simultaneous targeting of DNA and E2F1 methylation.
    Montenegro MF; Sáez-Ayala M; Piñero-Madrona A; Cabezas-Herrera J; Rodríguez-López JN
    PLoS One; 2012; 7(12):e52231. PubMed ID: 23251702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotinamide sensitizes human breast cancer cells to the cytotoxic effects of radiation and cisplatin.
    Domínguez-Gómez G; Díaz-Chávez J; Chávez-Blanco A; Gonzalez-Fierro A; Jiménez-Salazar JE; Damián-Matsumura P; Gómez-Quiroz LE; Dueñas-González A
    Oncol Rep; 2015 Feb; 33(2):721-8. PubMed ID: 25504347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative promoter hypermethylation analysis of cancer-related genes in salivary gland carcinomas: comparison with methylation-specific PCR technique and clinical significance.
    Lee ES; Issa JP; Roberts DB; Williams MD; Weber RS; Kies MS; El-Naggar AK
    Clin Cancer Res; 2008 May; 14(9):2664-72. PubMed ID: 18451230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clofarabine, a novel adenosine analogue, reactivates DNA methylation-silenced tumour suppressor genes and inhibits cell growth in breast cancer cells.
    Lubecka-Pietruszewska K; Kaufman-Szymczyk A; Stefanska B; Cebula-Obrzut B; Smolewski P; Fabianowska-Majewska K
    Eur J Pharmacol; 2014 Jan; 723():276-87. PubMed ID: 24296317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-Aza-2'-Deoxycytidine and CDDP Synergistically Induce Apoptosis in Renal Carcinoma Cells via Enhancing the APAF-1 Activity.
    Zhu X; Yi F; Chen P; Chen L; Zhang X; Cao C; Tan W
    Clin Lab; 2015; 61(12):1821-30. PubMed ID: 26882803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of promoter hypermethylation of RASSF1A, RARbeta2, BRCA1 and HOXA5 in breast cancers of Indian patients.
    Bagadi SA; Prasad CP; Kaur J; Srivastava A; Prashad R; Gupta SD; Ralhan R
    Life Sci; 2008 Jun; 82(25-26):1288-92. PubMed ID: 18538349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lidocaine and ropivacaine, but not bupivacaine, demethylate deoxyribonucleic acid in breast cancer cells in vitro.
    Lirk P; Hollmann MW; Fleischer M; Weber NC; Fiegl H
    Br J Anaesth; 2014 Jul; 113 Suppl 1():i32-8. PubMed ID: 24946779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylation of conserved CpG sites neighboring the beta retinoic acid response element may mediate retinoic acid receptor beta gene silencing in MCF-7 breast cancer cells.
    Arapshian A; Kuppumbatti YS; Mira-y-Lopez R
    Oncogene; 2000 Aug; 19(35):4066-70. PubMed ID: 10962564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curcumin inhibits growth of human breast cancer cells through demethylation of DLC1 promoter.
    Liu Y; Zhou J; Hu Y; Wang J; Yuan C
    Mol Cell Biochem; 2017 Jan; 425(1-2):47-58. PubMed ID: 27830358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimetastatic gene expression profiles mediated by retinoic acid receptor beta 2 in MDA-MB-435 breast cancer cells.
    Wallden B; Emond M; Swift ME; Disis ML; Swisshelm K
    BMC Cancer; 2005 Oct; 5():140. PubMed ID: 16255778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenovirus-mediated expression of MOAP-1, Bax and RASSF1A antagonizes chemo-drug resistance of human breast cancer cells expressing cancer stem cell markers.
    Tan EW; Abdullah ADI; Ming LC; Poh CL; Goh BH; Lau TP; Tan KO
    Biomed Pharmacother; 2024 Jul; 176():116744. PubMed ID: 38810399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Constitutively active ErbB2 regulates cisplatin-induced cell death in breast cancer cells via pro- and antiapoptotic mechanisms.
    Sigurðsson HH; Olesen CW; Dybboe R; Lauritzen G; Pedersen SF
    Mol Cancer Res; 2015 Jan; 13(1):63-77. PubMed ID: 25143433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folic acid enforces DNA methylation-mediated transcriptional silencing of PTEN, APC and RARbeta2 tumour suppressor genes in breast cancer.
    Lubecka-Pietruszewska K; Kaufman-Szymczyk A; Stefanska B; Fabianowska-Majewska K
    Biochem Biophys Res Commun; 2013 Jan; 430(2):623-8. PubMed ID: 23219837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between tumor DNA methylation status and patient characteristics in African-American and European-American women with breast cancer.
    Wang S; Dorsey TH; Terunuma A; Kittles RA; Ambs S; Kwabi-Addo B
    PLoS One; 2012; 7(5):e37928. PubMed ID: 22701537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.